nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenindamine—HRH1—Histamine receptors—HRH3—narcolepsy	0.249	0.282	CbGpPWpGaD
Phenindamine—Mirtazapine—HRH3—narcolepsy	0.0536	0.463	CrCbGaD
Phenindamine—HRH1—Amine ligand-binding receptors—HRH3—narcolepsy	0.0387	0.0438	CbGpPWpGaD
Phenindamine—HRH1—Monoamine GPCRs—HTR2A—narcolepsy	0.023	0.026	CbGpPWpGaD
Phenindamine—HRH1—G alpha (q) signalling events—HCRTR1—narcolepsy	0.0211	0.0238	CbGpPWpGaD
Phenindamine—HRH1—G alpha (q) signalling events—HCRTR2—narcolepsy	0.0211	0.0238	CbGpPWpGaD
Phenindamine—HRH1—G alpha (q) signalling events—P2RY11—narcolepsy	0.0203	0.023	CbGpPWpGaD
Phenindamine—HRH1—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0193	0.0218	CbGpPWpGaD
Phenindamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.0188	0.0213	CbGpPWpGaD
Phenindamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.0188	0.0213	CbGpPWpGaD
Phenindamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.0182	0.0206	CbGpPWpGaD
Phenindamine—HRH1—G alpha (q) signalling events—HCRT—narcolepsy	0.0173	0.0196	CbGpPWpGaD
Phenindamine—HRH1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0163	0.0184	CbGpPWpGaD
Phenindamine—HRH1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0163	0.0184	CbGpPWpGaD
Phenindamine—HRH1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0157	0.0178	CbGpPWpGaD
Phenindamine—Epinastine—HTR2A—narcolepsy	0.0155	0.134	CrCbGaD
Phenindamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.0155	0.0175	CbGpPWpGaD
Phenindamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.014	0.0158	CbGpPWpGaD
Phenindamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.014	0.0158	CbGpPWpGaD
Phenindamine—HRH1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0135	0.0152	CbGpPWpGaD
Phenindamine—HRH1—G alpha (q) signalling events—TRH—narcolepsy	0.0131	0.0148	CbGpPWpGaD
Phenindamine—Mirtazapine—HTR2A—narcolepsy	0.0122	0.106	CrCbGaD
Phenindamine—Cyproheptadine—HTR2A—narcolepsy	0.0119	0.102	CrCbGaD
Phenindamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.0117	0.0133	CbGpPWpGaD
Phenindamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0115	0.013	CbGpPWpGaD
Phenindamine—HRH1—GPCR ligand binding—HCRTR1—narcolepsy	0.0106	0.012	CbGpPWpGaD
Phenindamine—HRH1—GPCR ligand binding—HCRTR2—narcolepsy	0.0106	0.012	CbGpPWpGaD
Phenindamine—HRH1—GPCR ligand binding—P2RY11—narcolepsy	0.0103	0.0116	CbGpPWpGaD
Phenindamine—HRH1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.0102	0.0116	CbGpPWpGaD
Phenindamine—HRH1—G alpha (q) signalling events—NPS—narcolepsy	0.00953	0.0108	CbGpPWpGaD
Phenindamine—HRH1—G alpha (q) signalling events—TAC1—narcolepsy	0.00953	0.0108	CbGpPWpGaD
Phenindamine—Mianserin—HTR2A—narcolepsy	0.00899	0.0776	CrCbGaD
Phenindamine—HRH1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00889	0.0101	CbGpPWpGaD
Phenindamine—HRH1—GPCR ligand binding—HCRT—narcolepsy	0.00873	0.00987	CbGpPWpGaD
Phenindamine—HRH1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00868	0.00982	CbGpPWpGaD
Phenindamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00852	0.00964	CbGpPWpGaD
Phenindamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00852	0.00964	CbGpPWpGaD
Phenindamine—Nortriptyline—HTR2A—narcolepsy	0.00804	0.0694	CrCbGaD
Phenindamine—HRH1—GPCR ligand binding—PENK—narcolepsy	0.00778	0.0088	CbGpPWpGaD
Phenindamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00761	0.00861	CbGpPWpGaD
Phenindamine—HRH1—GPCR ligand binding—TRH—narcolepsy	0.00661	0.00748	CbGpPWpGaD
Phenindamine—HRH1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00631	0.00714	CbGpPWpGaD
Phenindamine—HRH1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00631	0.00714	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—HCRTR1—narcolepsy	0.006	0.00679	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—HCRTR2—narcolepsy	0.006	0.00679	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—P2RY11—narcolepsy	0.0058	0.00656	CbGpPWpGaD
Phenindamine—HRH1—GPCR ligand binding—HRH3—narcolepsy	0.0058	0.00656	CbGpPWpGaD
Phenindamine—HRH1—G alpha (q) signalling events—HTR2A—narcolepsy	0.00573	0.00648	CbGpPWpGaD
Phenindamine—Amitriptyline—HTR2A—narcolepsy	0.00558	0.0481	CrCbGaD
Phenindamine—HRH1—Signaling by GPCR—HCRTR1—narcolepsy	0.00545	0.00617	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—HCRTR2—narcolepsy	0.00545	0.00617	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—P2RY11—narcolepsy	0.00527	0.00596	CbGpPWpGaD
Phenindamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00513	0.0058	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—HCRT—narcolepsy	0.00493	0.00558	CbGpPWpGaD
Phenindamine—HRH1—GPCR ligand binding—NPS—narcolepsy	0.0048	0.00543	CbGpPWpGaD
Phenindamine—HRH1—GPCR ligand binding—TAC1—narcolepsy	0.0048	0.00543	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—HCRT—narcolepsy	0.00448	0.00506	CbGpPWpGaD
Phenindamine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00443	0.00501	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—PENK—narcolepsy	0.00439	0.00497	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—PENK—narcolepsy	0.00399	0.00451	CbGpPWpGaD
Phenindamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.0038	0.00429	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—TRH—narcolepsy	0.00374	0.00423	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—TRH—narcolepsy	0.00339	0.00384	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—HRH3—narcolepsy	0.00328	0.00371	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—HCRTR1—narcolepsy	0.00322	0.00364	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—HCRTR2—narcolepsy	0.00322	0.00364	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—P2RY11—narcolepsy	0.00311	0.00352	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—HRH3—narcolepsy	0.00298	0.00337	CbGpPWpGaD
Phenindamine—HRH1—GPCR ligand binding—HTR2A—narcolepsy	0.00289	0.00327	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—TAC1—narcolepsy	0.00272	0.00307	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—NPS—narcolepsy	0.00272	0.00307	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—HCRT—narcolepsy	0.00265	0.00299	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—TAC1—narcolepsy	0.00247	0.00279	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—NPS—narcolepsy	0.00247	0.00279	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—PENK—narcolepsy	0.00236	0.00267	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—TRH—narcolepsy	0.002	0.00227	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—HRH3—narcolepsy	0.00176	0.00199	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—HTR2A—narcolepsy	0.00163	0.00185	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—HTR2A—narcolepsy	0.00148	0.00168	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—TAC1—narcolepsy	0.00146	0.00165	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—NPS—narcolepsy	0.00146	0.00165	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—HTR2A—narcolepsy	0.000876	0.000991	CbGpPWpGaD
